Skip to main content
Charles Wykoff, MD, Ophthalmology, Katy, TX, Houston Methodist Hospital

CharlesCliftonWykoffMD

Ophthalmology Katy, TX

Retinal Disease

Physician

Dr. Wykoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wykoff's full profile

Already have an account?

Summary

  • Board Certified by the American Board of Ophthalmology. Partner at Retina Consultants of Houston & Clinical Assistant professor at Weill Cornell Medical College, Houston Methodist Hospital. Research interests: angiogenesis & exudative retinal diseases as well as vitreoretinal surgery topics including trauma, retinal detachments, diabetic retinopthay, & macular holes. Principle investigator on numerous clinical trials including novel approaches to treating AMD, RVO and diabetic retinopathy. Member of the Macula Society, ASRS, AAO, and ARVO.

Education & Training

  • B Palmer Eye Institute - A B Leach Eye
    B Palmer Eye Institute - A B Leach EyeChief Residency, Chief Resident & Co-Director of Ocular Trauma, 2010 - 2011
  • University of Miami Hospital and Clinics
    University of Miami Hospital and ClinicsFellowship, Surgical Retina and Vitreous, 2009 - 2011
  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemResidency, Ophthalmology, 2006 - 2009
  • Brigham and Womens Hospital
    Brigham and Womens HospitalInternship, Internal Medicine, 2005 - 2006
  • Harvard Medical School
    Harvard Medical SchoolClass of 2005

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2011 - 2024
  • FL State Medical License
    FL State Medical License 2009 - 2015
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Intravitreal Aflibercept with Optical Coherence Tomography Angiography Vessel Density in Patients with Proliferative Diabetic Retinopathy  
    Charles C Wykoff, Srinivas R Sadda, JAMA Ophthalmology
  • Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging with Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy  
    Lee M Jampol, Lloyd Paul Aiello, Jennifer K Sun, Szilard Kiss, Charles C Wykoff, Neil M Bressler, JAMA

Authored Content

  • Association of Intravitreal Aflibercept with Optical Coherence Tomography Angiography Vessel Density in Patients with Proliferative Diabetic RetinopathyJune 2020
  • Association of Intravitreal Aflibercept with Optical Coherence Tomography Angiography Vessel Density in Patients with Proliferative Diabetic RetinopathyJune 2020
  • Association of Intravitreal Aflibercept with Optical Coherence Tomography Angiography Vessel Density in Patients with Proliferative Diabetic RetinopathyJune 2020

Press Mentions

  • Sustained-Release Corticosteroid Implant Improves, Slows Progression of Diabetic Retinopathy
    Sustained-Release Corticosteroid Implant Improves, Slows Progression of Diabetic RetinopathyMarch 8th, 2017
  • Kodiak Sciences Announces Upcoming Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at American Academy of Ophthalmology 2019 Annual Meeting
    Kodiak Sciences Announces Upcoming Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at American Academy of Ophthalmology 2019 Annual MeetingOctober 7th, 2019
  • Kodiak Sciences Announces Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Academy of Ophthalmology Annu...
    Kodiak Sciences Announces Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Academy of Ophthalmology Annu...October 11th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations